X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GRPH

Closed

Graphite Bio Inc

22.26
-27.74 (-55.48%)
Last Update: 22 Mar 2024 16:30:00
Yesterday: 50.
Day's Range: 22.26 - 22.26
Send
When Written:
 
2.45
Graphite Bio Inc. is a biotechnology company that focuses on developing gene editing therapies for patients with serious genetic diseases. The company is based in Boston, Massachusetts, and was founded in 2018 by a team of experienced biotech executives and scientists. Graphite Bio's technology platform is based on the use of CRISPR/Cas9 gene editing to correct genetic mutations that cause diseases such as sickle cell anemia and beta-thalassemia. The company has raised over $150 million in funding from investors, including GV, Versant Ventures, and Samsara BioCapital. Graphite Bio is currently conducting preclinical studies and expects to begin clinical trials in the near future.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X